Bora has been awarded “Outstanding Company of the Year” by an independent panel of international judges during Bio-Asia Taiwan exhibit taking place in Taipei, Taiwan July 24-26, 2023. Bora was chosen from a short list of several candidates for its demonstrated leadership in the Taiwan Biopharma industry.
Bobby Sheng said; “Our team’s focused dedication to excellence in quality and customer service continues to be acknowledged by our clients and in BioPharma industry. I’m especially proud of our biologic subsidiary, Bora Biologics, for growing at such a rapid pace and being recognized in the Biopharma community.”
Bora is currently the only CDMO in Taiwan that has a leading position in both small and large molecules with 6 manufacturing sites with over 70 Billion NTD market cap.
